Cargando…
Lung cancer screening
Lung cancer is the primary cause of cancer mortality in developed countries. First diagnosis only when disease has already reached the metastatic phase is the main reason for failure in treatment. To this regard, although low-dose spiral computed tomography (CT) has proven to be effective in the ear...
Autor principal: | |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2883693/ https://www.ncbi.nlm.nih.gov/pubmed/20424610 http://dx.doi.org/10.1038/sj.bjc.6605660 |
_version_ | 1782182271724290048 |
---|---|
author | Pastorino, U |
author_facet | Pastorino, U |
author_sort | Pastorino, U |
collection | PubMed |
description | Lung cancer is the primary cause of cancer mortality in developed countries. First diagnosis only when disease has already reached the metastatic phase is the main reason for failure in treatment. To this regard, although low-dose spiral computed tomography (CT) has proven to be effective in the early detection of lung cancer (providing both higher resectability and higher long-term survival rates), the capacity of annual CT screening to reduce lung cancer mortality in heavy smokers has yet to be demonstrated. Numerous ongoing large-scale randomised trials are under way in high-risk individuals with different study designs. The initial results should be available within the next 2 years. |
format | Text |
id | pubmed-2883693 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-28836932011-06-08 Lung cancer screening Pastorino, U Br J Cancer Minireview Lung cancer is the primary cause of cancer mortality in developed countries. First diagnosis only when disease has already reached the metastatic phase is the main reason for failure in treatment. To this regard, although low-dose spiral computed tomography (CT) has proven to be effective in the early detection of lung cancer (providing both higher resectability and higher long-term survival rates), the capacity of annual CT screening to reduce lung cancer mortality in heavy smokers has yet to be demonstrated. Numerous ongoing large-scale randomised trials are under way in high-risk individuals with different study designs. The initial results should be available within the next 2 years. Nature Publishing Group 2010-06-08 2010-04-27 /pmc/articles/PMC2883693/ /pubmed/20424610 http://dx.doi.org/10.1038/sj.bjc.6605660 Text en Copyright © 2010 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Minireview Pastorino, U Lung cancer screening |
title | Lung cancer screening |
title_full | Lung cancer screening |
title_fullStr | Lung cancer screening |
title_full_unstemmed | Lung cancer screening |
title_short | Lung cancer screening |
title_sort | lung cancer screening |
topic | Minireview |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2883693/ https://www.ncbi.nlm.nih.gov/pubmed/20424610 http://dx.doi.org/10.1038/sj.bjc.6605660 |
work_keys_str_mv | AT pastorinou lungcancerscreening |